The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for February 19, 2021
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA


Brakke Consulting News
Pain Management Products report
2021 Industry Overview – still time to register!

Earnings News

Other News
Boehringer Ingelheim
Carus Animal Health
Chr Hansen
DaySmart Software
DLG Group
FVO – Brasília Indústria e Comércio de Alimentos
H.I.G. Capital
IK Investment Partners
Imbed Biosciences
Innovad Group
Jorgensen Laboratories
Vetter Software


Pain management is one of the leading topics in veterinary medicine today. Brakke Consulting’s annual report on Pain Management Products for Dogs and Cats includes such valuable information as:

– overview of acute and chronic pain in small animals
– discussion of the impact of the human opioid crisis on veterinary use of opioids
– review of new products, including performance of deracoxib generics
– estimates of US sales and prices of leading products
– pain management products in development, including monoclonal antibody products LIBRELA and SOLENSIA
– review of nutritional supplements used for chronic pain
– review of therapeutic diets for joint care
– discussion of the use of cannabinoids in veterinary pain management
– 2021 survey of 340 small animal veterinarians regarding use of pain management products

Pain Management Products for Dogs and Cats 2021 can be purchased for $5,500 if ordered by March 12, 2021, and $5,950 thereafter. The report will be completed in late March. Questions about the study can be answered by project manager Lynn Fondon, DVM, MBA at


  • Zoetis reported its financial results for the full year 2020. The company reported revenue of $6.7 billion, an increase of 7% compared with full year 2019. On an operational basis, revenue for full year 2020 increased 9%, excluding the impact of foreign exchange. Net income for full year 2020 was $1.6 billion, an increase of 9%. (company press release)
  • Nestle SA reported results for the full year 2020. PetCare sales were CHF 14,001 million ($15,855 million), an increase of 3% compared to the prior year. Underlying trading operating profit for the segment was CHF 3,081 million ($3,489 million), an increase of 6%. (company website)


New research on how veterinarians have been affected by the COVID-19 pandemic and their plans for the post-pandemic world will be an important feature of the annual Brakke Consulting Industry Overview, to be presented in a 90-minute webinar on Tuesday, Feb. 23 beginning at 11 am EST.

The new research examines the role of such things as curbside appointments and telemedicine, and how veterinarians plan to deploy them post-pandemic.  We also look at the impact of COVID-19 on the veterinary staff during this trying year, as well as make our predictions on what’s ahead for the industry in 2021.  There will also be an opportunity for questions from the audience.

In addition to the new research findings, the Overview will cover:

  • Top animal health company revenues, growth, and new product performance
  • A special analysis of changes in ecommerce and pet medication sales
  • Status of veterinary practice consolidation
  • Data on pet adoptions and pet population during the pandemic
  • New perspectives on the evolution of veterinary distribution
  • African Swine Fever, pandemic-driven packing plant closures and the future of technology on the farm animal market

The Brakke Industry Overview is an information-packed presentation geared to the interests of executive leadership, sales and marketing managers, financial executives and others involved in the industry.  The cost of attending the online Overview this year is reduced to $199.  To register, click here. Or, you can call Amanda McDavid, (336) 396-3916.  We look forward to having you join us.


  • Boehringer Ingelheim Animal Health USA Inc. announced the creation of Pawru, Inc. as a separate Company within the Boehringer Ingelheim Animal Health business. Pawru will encompass and expand the Boehringer Ingelheim’s digital collaborative animal healthcare platform, which has been known as PetPro Connect. The PetPro products will transition to Pawru branding. (PRNewswire)
  • Hill’s Pet Nutrition has agreed to pay $12.5 million to settle a consolidated class action lawsuit brought by owners of animals affected by canned dog foods recalled in 2018 and 2019 for containing toxic amounts of vitamin D. The preliminary settlement, approved February 2, is set for a final approval and fairness hearing on July 27. (Vet Advantage – VIN News)
  • Petco announced that employees who get vaccinated against COVID-19 will receive a $75 payment. For each employee who gets vaccinated, Petco will also contribute $25 to the Petco Partner Assistance Fund, which provides assistance to employees experiencing financial hardship. (Vet Advantage)
  • Chr Hansen announced it has established a new division focused on developing new microbial solutions for companion animals. The Pets Health & Nutrition branch is led by Dr. Lidiia Alaverdova, who was previously at Hill’s Pet Nutrition. (IHS Markit Connect)
  • knoell announced it is bringing all of its Animal Health CRO expertise and service brands under one name to provide a unified face to customers around the world. As of February 2021, Cyton and Triveritas will become knoell which creates one animal health team based in the US, EU, China, and the UK. (company press release)
  • Imbed Biosciences, a privately held biotech company in the advanced wound care field, announced that it has entered an exclusive distribution agreement with Jorgensen Laboratories (“Jorvet”) to distribute its MicroLyte VET wound dressings to veterinary hospitals and clinics in the U.S. and Canada. (company press release)
  • DaySmart Software announced the acquisition of Vetter Software, provider of cloud-based veterinary practice management software. This acquisition expands DaySmart’s pet services platform to serve veterinarians, groomers and kennel facilities. Financial terms were not disclosed. (Pet Age)
  • CANADA, BRAZIL Zoetis announced it has gained marketing authorizations for Librela (bedinvetmab) in Brazil and Canada to alleviate pain associated with osteoarthritis in dogs. Zoetis previously attained approval for Librela in the EU and Switzerland. (IHS Markit Connect)
  • UK Carus Animal Health announced an agreement with SpheriTech. The  worldwide exclusive license deal will see Carus develop and sell products for topical use based on SpheriTech’s patented SpheriSome technology in a range of veterinary applications. The first formulations to be developed by Carus using this technology will be based on poly-Ɛ-lysine, an antimicrobial peptide discovered in Japan in the 1980s. (IHS Markit Connect)
  • BELGIUM IK Investment Partners‘ (IK) IK IX Fund announced it will acquire a majority stake in Innovad Group (Innovad), a global supplier of animal health and nutrition solutions, primarily targeting the pigs and poultry as well as the ruminants segment. Innovad, headquartered in Belgium, serves 65 countries through local sales offices and a network of exclusive distributors. Financial terms were not disclosed. (
  • BRAZIL I.G. Capital announced that its affiliate has completed the acquisition of FVO – Brasília Indústria e Comércio de Alimentos LTDA., a leading pet food manufacturer in Brazil. FVO operates 5 industrial facilities, 9 distribution centers and reaches all 27 Brazilian states. Financial terms were not disclosed. (Globalpets)
  • FINLAND Alltech and Denmark’s DLG Group (a farm cooperative) are extending their existing partnership by creating a 50:50 joint venture focused on livestock nutrition in Scandinavia. The two firms are finalizing the purchase of Finnish company Kärki-Agri. The financial details of the transaction were not revealed. Previously, Alltech and DLG Group collaborated in 2017 to create a joint venture in the Russian premix sector. (IHS Markit Connect)



  • WORLD – ONE HEALTH The World Health Organization (WHO) chief said recently that the COVID-19 pandemic demonstrates “intimate” linkages between the health of humans, animals and ecosystems, as zoonotic diseases spread between animals and people. The WHO chief maintained that to keep people safe, One Health must be translated into local-level systems.  He pointed out that approximately 70% of all emerging and re-emerging pathogens are zoonotic, jumping from animals to humans, warning that “we don’t know when the next threat – the next disease X – will emerge”.  (
  • SWEDEN – DOG GENOME Uppsala University and the Swedish University of Agricultural Sciences announced they have used new methods of DNA sequencing and annotation to build a more complete dog reference genome. The expanded genome reduced the number of genome gaps from over 23,000 to 585. The new dog reference genome and annotation is available publicly for download or for online browsing via the University of California, Santa Cruz’s Genome Browser. (IHS Markit Connect)


The item about the WHO chief’s remarks on the linkage between human and animal health, and the related effects as zoonotic diseases spread between animals and people pulled me up short as I read it.  With all the voluminous reading that we’ve all done about COVID-19 in the past year, the topic of zoonosis is sometimes mentioned but rarely gets focus.  One Health and its local effects are still not part of the normal vernacular of our medical system.

The recent visit of WHO teams to Wuhan, China, and the resulting discussion of origins of COVID-19 serve to remind us that investment in a real One Health strategy might potentially have headed off at least some of the effect of this awful pandemic.  Whatever we saved as a society by not taking this seriously enough has been spent (in money and lives) many times over.  And most worrisome – could it happen again tomorrow?  Or is it happening again today somewhere in the world?  And are we any better positioned to use our knowledge of zoonotic disease and the One Health approach to stop it in its tracks?  Our industry plays a key role and we need to have a strong voice in shaping a global strategy.  We must do better next time.

Jim Kroman

Your View

Last week, we asked you about why you thought pet owners shop for pet products online and we offered seven statements for you to rank.  It was no surprise that almost 80% of the respondents said that convenience was the top reason for pet owners to shop online.  Interestingly, there wasn’t much difference in the ranking score between the next three reasons (#2 through #4, listed in order), which were finding better prices for products online, more easily comparison shop online and then find a broader selection of products online  The next three reason (#5 through #7, listed in order) were also very close but scored much lower, which were able to read product reviews, set purchases to use autoshipand pet medications and food could be bought at the same time.   So, convenience wins but price and being able to compare a broad selection of products are not too far behind.

This week, let’s ask about something we are all talking about…the weather.


This past week, how has the weather impacted you?  

en_USEnglish (United States)